Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

History and ongoing work of AORTIC

Dr James Holland - Mount Sinai Hospital, New York, USA
History and ongoing work of AORTIC ( Dr James Holland - Mount Sinai Hospital, New York, USA )
5 May 2014

AORTIC and the benefits of coordination between different US NCI-designated cancer centres in Kenya

Dr Lisa Stevens - National Cancer Institute, Bethesda, USA
AORTIC and the benefits of coordination between different US NCI-designated cancer centres in Kenya ( Dr Lisa Stevens - National Cancer Institute, Bethesda, USA )
5 May 2014

Subset of breast cancer patients found to benefit from neratinib in latest trial

Dr John W. Park - University of California San Francisco, San Francisco, USA
Subset of breast cancer patients found to benefit from neratinib in latest trial ( Dr John W. Park - University of California San Francisco, San Francisco, USA )
1 May 2014

Role of AORTIC in dealing with rising cancer rates in Africa

North American Vice president of AORTIC
Role of AORTIC in dealing with rising cancer rates in Africa ( North American Vice president of AORTIC )
1 May 2014

New drug demonstrates early promise in metastatic breast cancer

Dr Amita Patnaik - South Texas Accelerated Research Therapeutics, San Antonio, USA
New drug demonstrates early promise in metastatic breast cancer ( Dr Amita Patnaik - South Texas Accelerated Research Therapeutics, San Antonio, USA )
1 May 2014

New tools can help tackle flawed decision-making process for HER2- patients

Dr Matti Aapro - Multidisciplinary Oncology Institute, Clinique De Genolier, Switzerland
New tools can help tackle flawed decision-making process for HER2- patients ( Dr Matti Aapro - Multidisciplinary Oncology Institute, Clinique De Genolier, Switzerland )
4 Apr 2014

Genetic testing can improve selection of women with ER positive breast cancer for ten rather than five years of hormonal therapy

Prof Mitch Dowsett - The Institute of Cancer Research, London, UK
Genetic testing can improve selection of women with ER positive breast cancer for ten rather than five years of hormonal therapy ( Prof Mitch Dowsett - The Institute of Cancer Research, London, UK )
1 Apr 2014

EBCC 2014 key messages to doctors

Prof David Cameron - Edinburgh Cancer Centre, Edinburgh, UK
EBCC 2014 key messages to doctors ( Prof David Cameron - Edinburgh Cancer Centre, Edinburgh, UK )
1 Apr 2014

Ganetespib in first-line treatment of women with metastatic HER2 positive or triple negative breast cancer

Prof David Cameron - Edinburgh Cancer Centre, Edinburgh, UK
Ganetespib in first-line treatment of women with metastatic HER2 positive or triple negative breast cancer ( Prof David Cameron - Edinburgh Cancer Centre, Edinburgh, UK )
1 Apr 2014

The future of mCRPC treatment - expert discussion

Prof Li Ping Xie - Zhejiang University School of Medicine, Hangzhou, China and Prof Paul de Souza - University of Western Sydney, Sydney, Australia
The future of mCRPC treatment - expert discussion ( Prof Li Ping Xie - Zhejiang University School of Medicine, Hangzhou, China and Prof Paul de Souza - University of Western Sydney, Sydney, Australia )
21 Mar 2014

mCRPC management in Taiwan - expert interview

Prof Paul de Souza and Dr Wayne Yen-Hwa Chang
mCRPC management in Taiwan - expert interview ( Prof Paul de Souza and Dr Wayne Yen-Hwa Chang )
21 Mar 2014

PSA as a marker of disease in patients with prostate cancer and bone metastases

Prof Laurence Koltz, Prof Wolfgang Horninger, Prof Bertrand Tombal
PSA as a marker of disease in patients with prostate cancer and bone metastases ( Prof Laurence Koltz, Prof Wolfgang Horninger, Prof Bertrand Tombal )
28 Feb 2014